BioCardia, Inc.BCDANASDAQ
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P36
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q3 2025-1.33%
Q2 2025-1.98%
Q1 202537.14%
Q4 20241.49%
Q3 2024-98.71%
Q2 202414.05%
Q1 202417.34%
Q4 202323.26%
Q3 202323.50%
Q2 2023-22.68%
Q1 202314.30%
Q4 2022-48.47%
Q3 202224.34%
Q2 20229.25%
Q1 20222.45%
Q4 2021-13.26%
Q3 20217.95%
Q2 2021-51.47%
Q1 202144.10%
Q4 20208.69%
Q3 2020-67.65%
Q2 202025.55%
Q1 20207.98%
Q4 2019-118.36%
Q3 201935.72%
Q2 20197.90%
Q1 201922.72%
Q4 2018-61.92%
Q3 201828.56%
Q2 20187.30%
Q1 2018-19.07%
Q4 2017-43.16%
Q3 201716.13%
Q2 20179.18%
Q1 201778.94%
Q4 2016-299.80%
Q3 201610600.00%
Q2 2016-162.35%
Q1 2016-25.44%
Q4 2015262.86%